Newsmeme!
Discover News you didn't know existed
Cerebrospinal Fluid
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Pocket Doc
Published October 5, 2008, 10:14 pm, Chicago Flame
Dr. George Q: There's research supporting coffee every day and research that discourages it. What is the truth behind the daily caffeine fix? A: You're right about the contradictory reports. Caffeine has been a lightning rod for research into alleged health risks and benefits for a long time.
Repurposing Of Enbrel For Alzheimer's Disease
Published October 3, 2008, 6:07 am, Medical News Today
At Cambridge Healthtech Institute's Third Annual Drug Repositioning Summit on Monday, October 6 in Boston, the audience is scheduled to hear, as a Keynote Presentation, the story of how an individual physician has charted an entirely new course for a therapeutic which is already one of the most successful of all time.
Eli Lilly starts second global phase III trial of investigational Alzheimer's disease compound
Published October 2, 2008, 4:27 pm, News-Medical-Net
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
Repurposing of Enbrel for Alzheimer's Disease
Published October 2, 2008, 4:31 am, PRWeb
At Cambridge Healthtech Institute's Third Annual Drug Repositioning Summit on Monday, October 6 in Boston, the audience is scheduled to hear, as a Keynote Presentation, the story of how an individual physician has charted an entirely new course for a therapeutic which is already one of the most successful of all time. The Keynote Presentation, entitled "Repurposing of Enbrel for Alzheimer's ...
Lilly Announces Initiation Of Second Global Phase III Trial Of Investigational Alzheimer's Disease Compound
Published October 2, 2008, 3:07 am, Medical News Today
Eli Lilly and Company (NYSE: LLY) announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease. The study, called IDENTITY 2, is expected to enroll 1,100 patients from 22 countries.
Sion hospital opens stem cell centre
Published September 30, 2008, 7:58 pm, The Times of India
Ravindra Ahire, a farm labourer's son from Malegaon, is happy he can hobble across the road with his walker...
Suspicious Immune Molecule Elevated In MS Patients
Published September 30, 2008, 3:08 am, Medical News Today
A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease.
Ask the doctor: Constant pain is ruining my life
Published September 29, 2008, 3:20 pm, Daily Mail
Dr Martin Scurr has been treating patients for more than 30 years and is one of the country's leading GPs. Here he tackles fibromyalgia and mercury fillings while breastfeeding...
MS patients have higher spinal fluid levels of suspicious immune molecule
Published September 29, 2008, 9:01 am, EurekAlert!
( Washington University School of Medicine ) MS patients have higher spinal fluid levels of suspicious immune molecule.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |